ConductScience.org, home
Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
API referenceFor AI assistants

Trial · NCT01291108

Results by group48

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 48

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in Average Eye IOPAGN-210669 Followed by AGN-210669 + Bimatoprost VehicleBaseline - Hour 026.16Standard Deviation 2.169Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPBimatoprost Followed by Bimatoprost + Bimatoprost VehicleBaseline - Hour 025.98Standard Deviation 1.962Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPCombined AdjunctivesBaseline - Hour 026.26Standard Deviation 2.446Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPAGN-210669 Followed by AGN-210669 + Bimatoprost VehicleBaseline - Hour 423.91Standard Deviation 2.382Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPBimatoprost Followed by Bimatoprost + Bimatoprost VehicleBaseline - Hour 423.82Standard Deviation 2.301Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPCombined AdjunctivesBaseline - Hour 423.85Standard Deviation 2.553Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPAGN-210669 Followed by AGN-210669 + Bimatoprost VehicleBaseline - Hour 822.49Standard Deviation 1.338Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPBimatoprost Followed by Bimatoprost + Bimatoprost VehicleBaseline - Hour 822.35Standard Deviation 2.024Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPCombined AdjunctivesBaseline - Hour 822.79Standard Deviation 2.391Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPAGN-210669 Followed by AGN-210669 + Bimatoprost VehicleBaseline - Hour 1221.48Standard Deviation 2.467Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPBimatoprost Followed by Bimatoprost + Bimatoprost VehicleBaseline - Hour 1222.07Standard Deviation 2.596Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPCombined AdjunctivesBaseline - Hour 1221.73Standard Deviation 2.624Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPAGN-210669 Followed by AGN-210669 + Bimatoprost VehicleChange from Baseline at Day 57-Hr 0 (n=24,25,72)-7.57Standard Deviation 2.881Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPBimatoprost Followed by Bimatoprost + Bimatoprost VehicleChange from Baseline at Day 57-Hr 0 (n=24,25,72)-10.28Standard Deviation 3.190Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPCombined AdjunctivesChange from Baseline at Day 57-Hr 0 (n=24,25,72)-10.84Standard Deviation 3.460Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPAGN-210669 Followed by AGN-210669 + Bimatoprost VehicleChange from Baseline at Day 57-Hr 4 (n=24,25,72)-6.95Standard Deviation 2.503Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPBimatoprost Followed by Bimatoprost + Bimatoprost VehicleChange from Baseline at Day 57-Hr 4 (n=24,25,72)-8.95Standard Deviation 3.531Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPCombined AdjunctivesChange from Baseline at Day 57-Hr 4 (n=24,25,72)-8.79Standard Deviation 3.330Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPAGN-210669 Followed by AGN-210669 + Bimatoprost VehicleChange from Baseline at Day 57-Hr 8 (n=24,25,72)-5.57Standard Deviation 3.484Millimeters of Mercury (mmHg)
Change From Baseline in Average Eye IOPBimatoprost Followed by Bimatoprost + Bimatoprost VehicleChange from Baseline at Day 57-Hr 8 (n=24,25,72)-7.19Standard Deviation 3.198Millimeters of Mercury (mmHg)

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01291108/results

API referenceFor AI assistants